Evogene Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Ofer Haviv
Chief executive officer
US$401.0k
Total compensation
CEO salary percentage | 97.3% |
CEO tenure | 20yrs |
CEO ownership | n/a |
Management average tenure | 2.6yrs |
Board average tenure | 5.8yrs |
Recent management updates
Recent updates
We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate
Mar 05Will Evogene (TLV:EVGN) Spend Its Cash Wisely?
Oct 09Will Evogene (TLV:EVGN) Spend Its Cash Wisely?
Jun 26We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate
Mar 13Here's Why We're Watching Evogene's (TLV:EVGN) Cash Burn Situation
Oct 07We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate
Jun 16Will Evogene (TLV:EVGN) Spend Its Cash Wisely?
Mar 02Here's Why We're Not Too Worried About Evogene's (TLV:EVGN) Cash Burn Situation
May 28Companies Like Evogene (TLV:EVGN) Are In A Position To Invest In Growth
Jan 21What Can We Make Of Evogene's (TLV:EVGN) CEO Compensation?
Nov 30CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$24m |
Jun 30 2024 | n/a | n/a | -US$20m |
Mar 31 2024 | n/a | n/a | -US$21m |
Dec 31 2023 | US$401k | US$390k | -US$24m |
Sep 30 2023 | n/a | n/a | -US$20m |
Jun 30 2023 | n/a | n/a | -US$23m |
Mar 31 2023 | n/a | n/a | -US$25m |
Dec 31 2022 | US$464k | US$415k | -US$27m |
Sep 30 2022 | n/a | n/a | -US$31m |
Jun 30 2022 | n/a | n/a | -US$32m |
Mar 31 2022 | n/a | n/a | -US$29m |
Dec 31 2021 | US$530k | US$420k | -US$28m |
Sep 30 2021 | n/a | n/a | -US$29m |
Jun 30 2021 | n/a | n/a | -US$26m |
Mar 31 2021 | n/a | n/a | -US$24m |
Dec 31 2020 | US$592k | US$367k | -US$23m |
Sep 30 2020 | n/a | n/a | -US$21m |
Jun 30 2020 | n/a | n/a | -US$21m |
Mar 31 2020 | n/a | n/a | -US$21m |
Dec 31 2019 | US$538k | US$366k | -US$18m |
Sep 30 2019 | n/a | n/a | -US$18m |
Jun 30 2019 | n/a | n/a | -US$18m |
Mar 31 2019 | n/a | n/a | -US$19m |
Dec 31 2018 | US$517k | US$324k | -US$21m |
Sep 30 2018 | n/a | n/a | -US$21m |
Jun 30 2018 | n/a | n/a | -US$21m |
Mar 31 2018 | n/a | n/a | -US$21m |
Dec 31 2017 | US$649k | US$359k | -US$21m |
Compensation vs Market: Ofer's total compensation ($USD401.00K) is about average for companies of similar size in the IL market ($USD428.07K).
Compensation vs Earnings: Ofer's compensation has been consistent with company performance over the past year.
CEO
Ofer Haviv (58 yo)
20yrs
Tenure
US$401,000
Compensation
Mr. Ofer Haviv, CPA, served as Interim Chief Executive Officer of Lavie Bio Ltd. since January 2023. He has been Chief Executive Officer and President of Evogene Limited since December 2004 and served as i...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & President | 20yrs | US$401.00k | no data | |
Chief Executive Officer of AgPlenus Ltd | 3yrs | US$456.00k | no data | |
Chief Executive Officer of Biomica Ltd | 6.9yrs | US$339.00k | 0% ₪ 0 | |
Chief Executive Officer of Lavie Bio Ltd. | 1.7yrs | US$606.00k | no data | |
Chief Financial Officer | 2.7yrs | no data | 0% ₪ 0 | |
Head of Investor Relations | 1.5yrs | no data | no data | |
Vice President of Human Resources | 2.9yrs | no data | no data | |
Executive Vice President of Business Development | 2.5yrs | no data | 0% ₪ 0 | |
Chief Executive Officer of Casterra Ag Ltd. | less than a year | no data | no data | |
Chief Executive Officer of Ag Plenus Ltd. | less than a year | no data | no data | |
Vice President of Commercial of Lavie Bio Ltd. | no data | no data | no data |
2.6yrs
Average Tenure
55yo
Average Age
Experienced Management: EVGN's management team is considered experienced (2.6 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Director | 3.1yrs | no data | 0% ₪ 0 | |
Independent Director | 2.1yrs | no data | 0% ₪ 0 | |
Independent Director | 19.6yrs | no data | 1.23% ₪ 418.8k | |
Independent Chairperson of the Board | 8.3yrs | no data | 0% ₪ 0 | |
Independent Director | 6.1yrs | no data | 0% ₪ 0 | |
Independent Director | 5.8yrs | no data | 0% ₪ 0 | |
Scientific Advisor | 2.9yrs | no data | no data |
5.8yrs
Average Tenure
63.5yo
Average Age
Experienced Board: EVGN's board of directors are considered experienced (5.8 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 12:40 |
End of Day Share Price | 2024/12/22 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Evogene Ltd. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Scott Henry | Alliance Global Partners |
Benjamin Haynor | Alliance Global Partners |
Kristen Kluska | Cantor Fitzgerald & Co. |